100 withdrawn. 100 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 100 | Withdrawn 100 |
Follow Endocrine System Diseases: new trials by email Literature Review of Endocrine System Diseases trials Research Report on Endocrine System Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Metformin Versus Standard of Care Treatment in Pregnant Women With Prediabetes Metformin - Prediabetes; Complicating Pregnancy | Phase 4 | Withdrawn | Gianna Wilkie | 2025-06-01 | 2025-04-11 | |
| Letrozole Versus Hormonal Preparation in Frozen Cycles of PCOS Patients. Letrozole 2.5mg - Frozen Embryo Transfer, Polycystic Ovarian Disease | Phase 4 | Withdrawn | Dubai Fertility Center | 2023-08-01 | 2024-02-20 | |
| Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease Vitamin D, Placebo Oral Tablet - Restless Leg Disorder, Renal Disease Bone | Phase 4 | Withdrawn | University of Sao Paulo General Hospital | 2022-03-31 | 2021-09-30 | |
| Pediatric Risk of Hypothyroidism With Iodinated Contrast Media Iohexol, Iodixanol, Iopromide - Hypothyroidism | Phase 4 | Withdrawn | GE Healthcare | 2022-03-01 | 2022-04-20 | |
| Angiotensin II vs. Vasopressin in Septic Shock Angiotensin II, Vasopressin - Septic Shock | Phase 4 | Withdrawn | University of New Mexico | 2022-01-03 | 2024-03-15 | |
| Continuation of Metformin to Improve And Keep Peri-operative Glycemic Control Metformin, Placebo - Diabetes Mellitus Type 2 | Phase 4 | Withdrawn | McMaster University | 2022-01-01 | 2026-07-10 | |
| Dapagliflozin Effect on Erythropoiesis and Physical Fitness Dapagliflozin (Forxiga®), Hydrochlorothiazide 25 mg, Placebo matching Dapagliflozin - Type 2 Diabetes Mellitus (T2DM) | Phase 4 | Withdrawn | University Hospital Tuebingen | 2021-09-01 | 2021-12-15 | |
| Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes-----renal Substudy Allisartan Isoproxil, Amlodipine - Diabetes Mellitus, Type 2, Blood Pressure | Phase 4 | Withdrawn | Guangdong Provincial People's Hospital | 2021-09-01 | 2022-08-26 | |
| A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes Basal Insulin - Type 2 Diabetes, Type 2 Diabetes Treated With Insulin | Phase 4 | Withdrawn | Eli Lilly and Company | 2021-08-16 | 2021-08-24 | |
| Empagliflozin in Adolescent Diabetes Empagliflozin - type1diabetes | Phase 4 | Withdrawn | Ohio State University | 2021-07-01 | 2023-03-23 | |
| Effects of DPP4 Inhibition on COVID-19 Linagliptin, Insulin regimen - Coronavirus Infection, Type 2 Diabetes | Phase 4 | Withdrawn | University of Miami | 2021-06-30 | 2021-06-10 | |
| Evaluation of the Retina in Patients With Non-proliferative Diabetic Retinopathy After Aflibercept Injection in the Eye Aflibercept Injection, Sham injection - Retinopathy, Diabetic | Phase 4 | Withdrawn | University of Rochester | 2021-02-01 | 2021-05-05 | |
| Polydiuretic Therapy for Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus Bumetanide 0.5 mg, dapaglifozin 5 mg, eplerenone 25 mg - HF - Heart Failure, Diabetes Mellitus | Phase 4 | Withdrawn | Northwestern University | 2021-01-08 | 2022-05-10 | |
| Letrozole for Frozen Embryo Transfer (FET) in Patients With Polycystic Ovary Syndrome (PCOS) Letrozole, estradiol valerate - Infertility, Female, Polycystic Ovary Syndrome | Phase 4 | Withdrawn | CRG UZ Brussel | 2020-12-01 | 2021-01-08 | |
| Intraoperative Dexamethasone and Its Effect on Hyperglycemia Dexamethasone, No dexamethasone - Diabetes Mellitus | Phase 4 | Withdrawn | Ascension Health | 2020-09-15 | 2021-01-22 | |
| REGROUP: Renohemodynamic Effects empaGliflozin in vaRiOUs Populations Empagliflozin 10 MG, Placebo oral tablet, Caffeine - Diabetes Mellitus, Type 2, Chronic Kidney Diseases | Phase 4 | Withdrawn | Amsterdam UMC, location VUmc | 2020-07-01 | 2021-10-08 | |
| Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation Liraglutide - Type 2 Diabetes | Phase 4 | Withdrawn | Cedars-Sinai Medical Center | 2019-12-01 | 2019-09-30 | |
| Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients Clopidogrel, Prasugrel, Ticagrelor - Diabetes | Phase 4 | Withdrawn | Centre hospitalier de l'Université de Montréal (CHUM) | 2019-09-01 | 2019-07-24 | |
| Comparison of Intramuscular and Intravenous ACTH Stimulation Test in Normal Volunteers Cosyntropin - Adrenal Insufficiency | Phase 4 | Withdrawn | Johns Hopkins University | 2019-07-01 | 2019-05-10 | |
| Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 Diabetes Vortioxetine - Type2 Diabetes, Major Depressive Disorder | Phase 4 | Withdrawn | Todd Doyle | 2019-07-01 | 2022-11-29 |
Showing 20 of 100. Sign in to see all of them.
Diabetes Mellitus (36) · Diabetes Mellitus, Type 2 (30) · Polycystic Ovary Syndrome (8) · Diabetes Mellitus, Type 1 (5) · Diabetes, Gestational (5) · Hypertension (5) · Hypogonadism (5) · Infertility (5) · Coronary Artery Disease (4) · Diabetic Foot (4) · Adrenal Insufficiency (3) · Obesity (3) · Angina Pectoris (2) · Anovulation (2) · Depressive Disorder, Major (2)
Metabolic Diseases (66) · Nutritional and Metabolic Diseases (66) · Glucose Metabolism Disorders (64) · Diabetes Mellitus (34) · Female Urogenital Diseases and Pregnancy Complications (24) · Urogenital Diseases (24) · Pathological Conditions, Signs and Symptoms (19) · Female Urogenital Diseases (18) · Cardiovascular Diseases (17) · Gonadal Disorders (17) · Vascular Diseases (16) · Neoplasms (12) · Adnexal Diseases (11) · Genital Diseases (11)
Metformin (13) · Hydrochlorothiazide (4) · Insulin Aspart (4) · Insulin Glargine (4) · Insulin Lispro (4) · Amlodipine (3) · Dexamethasone (3) · Estradiol (3) · Exenatide (3) · Glyburide (3) · Insulin (3) · Sitagliptin Phosphate (3) · dapagliflozin (3) · empagliflozin (3) · Clomiphene (2)
Emory University (3) · University Magna Graecia (3) · Cedars-Sinai Medical Center (2) · GE Healthcare (2) · Georgetown University (2) · Johns Hopkins University (2) · Mohamed Sayed Abdelhafez (2) · University of Texas Southwestern Medical Center (2) · Amsterdam UMC, location VUmc (1) · Anemia Working Group Romania (1) · Ascension Health (1) · Asociación para Evitar la Ceguera en México (1) · Assistance Publique - Hôpitaux de Paris (1) · AstraZeneca (1) · Bayer (1)
United States (42) · Canada (5) · Italy (5) · Brazil (3) · Germany (3) · United Kingdom (3) · Australia (2) · Egypt (2) · Austria (1) · Finland (1) · India (1) · Jamaica (1) · Latvia (1) · Mexico (1) · Netherlands (1)
Achille Tolino, MD (3) · Francesco Orio, MD (3) · Stefano Palomba, MD (3) · Ahmed Gibreel, Dr (2) · Mohamed S Abdelhafez, Dr (2) · Adrian Vella, MD (1) · Ahmed A Abdel Azim, MD (1) · Ahmed A. Dahab, MD (1) · Alfonso Calle, MD (1) · Alpana P Shukla, MD (1) · Andrea L. Kossler, M.D. (1) · Andrew N Antoszyk, MD (1) · Anil Bhansali, MD,DM (1) · Ayman GA Elnahry, Msc (1)
PMID 10321661, PMID 10697064, PMID 10923728, PMID 12186604, PMID 18784623, PMID 20600032, PMID 29600824, PMID 3029157, PMID 32178593, PMID 32224164, PMID 3306374, PMID 34412687, PMID 38189593, PMID 38770818, PMID 4101232, PMID 6270176, PMID 6384785, PMID 7600840, PMID 7634816, PMID 7638758, PMID 8815944, PMID 8855809, PMID 9559600
2008 (1), 2015 (1), UL1TR001449 (1)